Catastrophic antiphospholipid syndrome (Q80167214)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932661%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Catastrophic antiphospholipid syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932661%20AND%20SRC:MED&resulttype=core&format=json

catastrophic antiphospholipid syndrome

29 December 2019

main subject

0 references

author name string

Joan T Merrill

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932661%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Ronald A Asherson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932661%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932661%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Rheumatology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932661%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932661%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932661%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

81-89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932661%20AND%20SRC:MED&resulttype=core&format=json

Catastrophic antiphospholipid syndrome: a rare cause of disseminated microvascular thrombotic injury - a case report with pathological and molecular correlative studies

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Long term outcome of catastrophic antiphospholipid syndrome survivors

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Catastrophic antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

The catastrophic antiphospholipid syndrome 1996: acute multi-organ failure associated with antiphospholipid antibodies: a review of 31 patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

The catastrophic antiphospholipid (Asherson's) syndrome in 2004--a review

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Catastrophic antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS).

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Neurological involvement as a poor prognostic factor in catastrophic antiphospholipid syndrome: autopsy findings in 12 cases

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Imaging findings in the rare catastrophic variant of the primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Catastrophic antiphospholipid syndrome in the intensive care unit

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Thrombotic storm: when thrombosis begets thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Antiphospholipid syndrome infectious origin

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Catastrophic antiphospholipid syndrome: response to repeated plasmapheresis over three years

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Thrombotic microangiopathy with liver, gut, and bone infarction (catastrophic antiphospholipid syndrome) associated with HELLP syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Susac's syndrome or catastrophic antiphospholipid syndrome?

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Molecular mechanisms in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Disseminated intravascular coagulation, antiphospholipid antibodies, and ischaemic necrosis of extremities

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Occurrence of thrombotic thrombocytopenic purpura in a systemic lupus erythematosus patient with antiphospholipid antibodies in association with a decreased activity of von Willebrand factor-cleaving protease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Prevention of thrombosis with prostaglandin E1 in a patient with catastrophic antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Isolation and characterization of cysteine proteinase in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Role of transforming growth factor beta1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Endothelial cell activation in thrombotic thrombocytopenic purpura (TTP): a prospective analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Catastrophic antiphospholipid syndrome: remission following leg amputation in 2 cases

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Protein C and other cofactors involved in the binding of antiphospholipid antibodies: relation to the pathogenesis of thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0069

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0069

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932661%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference